IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 218 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,646,753 | +1123.6% | 248,755 | +1109.8% | 0.04% | +950.0% |
Q1 2023 | $216,312 | +116825.4% | 20,562 | +38.0% | 0.00% | +33.3% |
Q4 2022 | $185 | -99.9% | 14,903 | -0.6% | 0.00% | 0.0% |
Q3 2022 | $155,000 | -10.4% | 14,989 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $173,000 | -8.0% | 14,989 | +0.1% | 0.00% | 0.0% |
Q1 2022 | $188,000 | -12.1% | 14,974 | -18.5% | 0.00% | 0.0% |
Q4 2021 | $214,000 | +7.5% | 18,383 | +20.9% | 0.00% | 0.0% |
Q3 2021 | $199,000 | +33.6% | 15,201 | +31.7% | 0.00% | +50.0% |
Q2 2021 | $149,000 | 0.0% | 11,544 | -13.4% | 0.00% | 0.0% |
Q1 2021 | $149,000 | -27.0% | 13,337 | -25.6% | 0.00% | 0.0% |
Q4 2020 | $204,000 | – | 17,931 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
13D Management LLC | 650,455 | $8,371,000 | 2.88% |
BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |